UPDATE 1-Valeant, Ackman get Oct. 6 trial over Allergan special meeting

WILMINGTON, Del., Aug 27 (Reuters) - Valeant Pharmaceuticals International Inc and activist investor William Ackman got their request for an expedited trial on Wednesday over the timing of a special meeting of Allergan Inc shareholders, a key to their $49 billion hostile takeover fight.